CIK 0001062822
- Non-accelerated filer
- Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760474169
- Phone
- +1 281-863-3000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-26 | COATS LONNEL Chief Executive Officer | Purchase | +10,000 | $2.18 | $22K | 804,359 |
| 2023-06-23 | McDermott Wendy VP, Human Resources | Purchase | +10,000 | $2.43 | $24K | 22,478 |
| 2023-06-23 | COATS LONNEL Chief Executive Officer | Purchase | +10,000 | $2.50 | $25K | 794,359 |
| 2023-06-22 | COATS LONNEL Chief Executive Officer | Purchase | +40,000 | $2.31 | $92K | 784,359 |
| 2023-06-20 | WADE JEFFREY L President and CFO | Purchase | +10,000 | $2.34 | $23K | 252,341 |
| 2023-06-20 | WADE JEFFREY L President and CFO | Purchase | +2,000 | $2.33 | $5K | 254,341 |
| 2023-06-05 | Artal International S.C.A. Director | Purchase | +27,775,050 | $2.60 | $72.2M | 78,634,381 |
| 2023-05-21 | Swain Judith L Director | Exercise or conversion | +9,302 | 40,332 | ||
| 2023-05-21 | Swain Judith L Director | Exercise or conversion · Restricted Stock Units | −9,302 | 0 | ||
| 2023-05-21 | SOBECKI CHRISTOPHER J Director | Exercise or conversion | +9,302 | 159,023 | ||
| 2023-05-21 | SOBECKI CHRISTOPHER J Director | Exercise or conversion · Restricted Stock Units | −9,302 | 0 | ||
| 2023-05-21 | Palantoni Frank Director | Exercise or conversion | +9,302 | 40,332 | ||
| 2023-05-21 | Palantoni Frank Director | Exercise or conversion · Restricted Stock Units | −9,302 | 0 | ||
| 2023-05-21 | NIES ALAN S Director | Exercise or conversion | +9,302 | 41,046 | ||
| 2023-05-21 | NIES ALAN S Director | Exercise or conversion · Restricted Stock Units | −9,302 | 0 | ||
| 2023-05-21 | LEFKOWITZ ROBERT J MD Director | Exercise or conversion | +9,302 | 40,332 | ||
| 2023-05-21 | LEFKOWITZ ROBERT J MD Director | Exercise or conversion · Restricted Stock Units | −9,302 | 0 | ||
| 2023-05-21 | DEBBANE RAYMOND Director | Exercise or conversion | +9,302 | 340,847 | ||
| 2023-05-21 | DEBBANE RAYMOND Director | Exercise or conversion · Restricted Stock Units | −9,302 | 0 | ||
| 2023-05-21 | BARKER SAM L Director | Exercise or conversion | +9,302 | 79,617 |
Page 16 of 27 · 540 trades